Table 3.
Effect of adropin on liver enzyme markers of control, hyperlipidemic, and adropin-treated groups of rat
| Groups | C (n=7) | H (n=7) | A (n=7) | P |
|---|---|---|---|---|
| AST (U/l) | 147.0 ±11.5a | 162.7 ± 10.3b | 82.3 ±5.65ab | 0.012 |
| ALT (U/l) | 72.5 ± 2.41a | 89.4 ± 4.48ab | 65.4 ± 3.90b | 0.007 |
| ALP (U/l) | 176.5 ± 25.9 | 229.7 ± 16.1a | 184.2 ± 18.9a | 0.111 |
| GGT (U/l) | 1.28 ± 0.18a | 2.42 ± 0.20ab | 1.42 ± 0.20b | 0.006 |
C: control, H: hyperlipidemic, A: adropin treatment groups, AST: aspartate transaminase, ALT: alanine transaminase, ALP: alkaline phosphatase, GGT: gama glutamil transferaz; P: Shows the differences between all groups (Kruskal-Wallis test)
a,b
In each line, the difference between the means with same letters are significant, P≤0.05 (Mann-Whitney U test)